← Back to Search

Exercise Training for Long COVID

N/A

Recruiting

Research Sponsored by University of Colorado, Denver

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 weeks

Awards & highlights

Study Summary

This trial will explore the effects of exercise training on Long COVID patients to better understand the condition and how to treat it.

Who is the study for?

This trial is for adults over 18 who've had COVID-19 and are now experiencing Long COVID symptoms that have lasted more than a month. It's not for those with severe obesity, older than 65, or with exercise intolerance due to non-cardiorespiratory conditions, recent serious blood clots, heart inflammation from COVID, or pre-existing heart/lung diseases.Check my eligibility

What is being tested?

The study aims to see if exercise training can help people with Long COVID by improving their quality of life and physical function. Researchers will also look into how the condition affects heart and lung health as well as body's response to stress.See study design

What are the potential side effects?

Since the intervention involves exercise, potential side effects may include muscle soreness, fatigue, shortness of breath during activity (especially given the target population), and an increased risk of injury if not properly monitored.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Characterizing the impact of exercise training (cardiac rehabilitation) on HRqOL among patients with Long COVID

Characterizing the impact of exercise training (cardiac rehabilitation) on functional capacity among patients with Long COVID

Secondary outcome measures

Characterization of abnormalities contributing to Long COVID

Identify the mechanism by which exercise training improves functional capacity and HRqOL among patients with Long COVID

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: ExerciseExperimental Treatment1 Intervention

Group II: ControlActive Control1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Exercise

2016

Completed Phase 1

~760

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor

1,732 Previous Clinical Trials

2,143,553 Total Patients Enrolled

Media Library

Exercise Clinical Trial Eligibility Overview. Trial Name: NCT05566483 — N/A

Post-COVID Syndrome Research Study Groups: Exercise, Control

Post-COVID Syndrome Clinical Trial 2023: Exercise Highlights & Side Effects. Trial Name: NCT05566483 — N/A

Exercise 2023 Treatment Timeline for Medical Study. Trial Name: NCT05566483 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the aggregate population of participants engaging in this research?

"Affirmative. According to information on clinicaltrials.gov, recruitment for this medical experiment is still ongoing; it was initially posted on 3/1/2023 and revised most recently on 5/9/2023 with the intention of enlisting 30 individuals at 1 site."

Answered by AI

Are elders being admitted to this experiment?

"To qualify for this specific trial, the patient's age must be between 18-65. For those outside that range, 116 studies are open to minors while 708 trials are available for elderly populations."

Answered by AI

Are there still opportunities to enroll in this experiment?

"Affirmative. Information available on clinicaltrials.gov suggests that this medical trial, initially posted in March of 2023, is currently enrolling participants. The study requires 30 patients to be recruited from a single location."

Answered by AI

Is enrollment available for this research trial?

"This medical trial is looking for 30 adults aged 18-65 that have been diagnosed with post-covid syndrome. To be considered eligible, patients must display symptoms consistent with Long COVID persisting for over 4 weeks following diagnosis and a documented history of contracting the virus."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Physiology of Long COVID-19 and the Impact of Cardiopulmonary Rehabilitation on Quality-of-Life and Functional Capacity

2023. "Physiology of Long COVID-19 and the Impact of Cardiopulmonary Rehabilitation on Quality-of-Life and Functional Capacity". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05566483.

All > Survivor Corps